HotSheets 2011

January February March April May June July August September October November December

January | Newsletter | Cover Letter

Us TOO Board Welcomes New Member
FDA Approves Xgeva® (denosumab) to Help Prevent Cancer-Related Bone Injury
US Panel Backs Provenge® for Medicare
FDA Panel Rejects Prostate Drugs (Avodart® & Proscar®) for Prostate Cancer Prevention
Could a Prostate Cancer Treatment Raise Colon Cancer Risk?
Clinical Staging for Prostate Cancer Can’t Predict Likelihood for Recurrence
Long-Term Effect of Early Postoperative Pelvic Floor Biofeedback on Continence post-RP
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Can dogs really smell prostate cancer in urine?”
Doctor Chodak’s Bottom Line
Prostate Biopsies Are Not Associated with Increased Mortality
DHT May Not Affect Prostate Size But May Reduce Bone Mineral Density
Read more..

February | Newsletter | Cover Letter

Special Burning Issues Supplement: A Systems Pathology Approach to Post-Surgical Patients with Anxiety
Dutasteride Enhances the Predictive Usefulness of PSA As a Screening Test
Is Prostate Cancer in Older Men More Deadly?
Us TOO Names New Board Officers, Another Member for 2011
Popular Online Prostate Cancer Tool Questioned
Cancer Blood Test Closer to Market
Older Men Get Less Effective Cancer Care
Decision Making in Localized Prostate Cancer: Lessons Learned from an Online Support Group
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – Creatine Supplements
ADT May Be Tied to Cataracts
Doctor Chodak’s Bottom Line
Read more..

March | Newsletter | Cover Letter

Us TOO 2009 Annual Report Now Available
Focusing on the Stress of Prostate Cancer
Gene Test May Spot Lethal Prostate Tumors
First 5-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Improving Active Surveillance Outcome Using Stringent Enrollment Criteria
Surgery vs. Radiation for High-Risk Disease
Multidisciplinary vs. 1-on-1 Medical Care
Prostate Cancer Support Groups, Health Literacy & Consumerism
PSA & Confirmatory Biopsy in Surveillance
Cancer Death Rates in African Americans Still High
Timely Intervention with Zoledronic Acid Beneficial
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “IOM Barely Changes Vitamin D Recommendations”
Doctor Chodak’s Bottom Line
Read more..

April | Newsletter | Cover Letter

Study Knocks Diagnostic Value of PSA Velocity
Imaging Misses Mark in Prostate Cancer
Large Study Shows Little Need for PSA Testing Beyond 10 Years Post-Surgery
PSA Testing Declines a Bit
Genetic Map of Prostate Cancer Cracked
Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radiotherapy-Recurrent Prostate Cancer
Study Suggests Lower PSA Cutoff for Biopsy
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Resistance Exercises vs. Calcium + Vitamin D”
Doctor Chodak’s Bottom Line
Drug (Abiraterone) Works in Most Prostate Cancer Subgroups
Read more..

May | Newsletter | Cover Letter

20% Rise in Number of Cancer Survivors
PSA Screening Is Higher in Men in Their 70s
Short Course of ADT Works Well with RT
Statins + RT More Effective in Prostate Cancer
New Cancer Drug Heads to Clinical Trials
Phase I/II Study of TRC105 in Refractory CRPC
Digoxin Possible Treatment for Prostate Cancer?
NCCN Continues to Modify Guidelines
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “An aspirin a day may reduce the risk of cancer”
Doctor Chodak’s Bottom Line
How Prostate Cancer May Spread to Bone
Read more..

June | Newsletter | Cover Letter

FDA Approves Abiraterone
Early Surgery or Watchful Waiting?
Biopsy May Progress without PSA Changes
Study Supports Watchful Waiting for Low-Risk Prostate Cancer
Another Endothelin Blocker Fails
Upgrade in Gleason Score Between Biopsies & Pathology Following Radical Prostatectomy
Overtreatment of Men with Low-Risk Prostate Cancer and Significant Comorbidity
Phase III Trial of Ipilimumab (NCT01057810)
Supplements Don’t Prevent Prostate Cancer
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Is Omega-3 in fish oil really bad for you?”
Doctor Chodak’s Bottom Line
Read more..

July | Newsletter | Cover Letter

Alpharadin (222Radium Chloride) Improves Overall Survival in Men with Metastatic CRPC
Early PSA Testing & Risk of Long-Term Death
Surgery Works in Locally-Advanced Disease
AS Update from the John Hopkins Experience
Effect of Surgery Delay in Men Undergoing AS
NADiA ProsVue - A New Prognostic Prostate Cancer Test (for Post-RP Patients)
Exelixis Drug Shown to Control Solid Tumors
Fusion of MRI and Prostate Ultrasound
Intermittent Vs. Continuous ADT
Circulating Tumor Cells Predict Drug Response
Ask Doctor Snuffy Myers
Doctor Chodak’s Bottom Line
Doc Moyad’s “No Bogus Science” Column – “___ Dietary Supplement Fights/Kills Prostate Cancer? Should Doc Moyad Support It?”
Read more..

August | Newsletter | Cover Letter

Medicare Will Pay for Prostate Cancer Drug
Long-Term Efficacy of the Phase 1-2 Study of MDV3100 in Advanced Prostate Cancer Patients Before and after Docetaxel Therapy
New Resource Kit from Us TOO for Men with Advanced Prostate Cancer
Potential Combinability of Custirsen with MDV3100 and Hsp90 Inhibitors to Enhance Anti-Tumor Activity Against Prostate Cancer
Kyphon® Balloon Kyphoplasty for Treating Spinal Fractures in Prostate Cancer Patients
Prostate Cancer in Men Less than 50 Years Old: A Comparison of Race and Outcomes
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “You want another reason to lose weight? How about free vitamin D?!”
Doctor Chodak’s Bottom Line
Hydrodissection in Nerve-Sparing Radical Prostatectomy Improves Postoperative Potency
Read more..

September | Newsletter | Cover Letter

Urine Test May Help Detect / Stratify Prostate Cancer
For Some Prostate Cancer Patients, Combo Treatment Improved Survival
Us TOO Names New Board Members for 2011
Robot Technology May Drive Up Prostate Surgeries
Letter to the Editors
New Patient Information Guide for CyberKnife
Age Adjustment in Active Surveillance
ADT & 11C-Choline Uptake in PET/CT Scans
Bone Flare with Abiraterone Treatment
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Some vegetables may reduce the risk of prostate cancer recurring after treatment”
Doctor Chodak’s Bottom Line
Read more..

October | Newsletter | Cover Letter

ADT Does Not Increase Cardiovascular Risk
Five Genes Liked to Aggressive Prostate Cancer
VA Adds to List of Agent Orange-Exposed Ships
Two Clusterin Studies Released
Good Long-Term QOL after Brachytherapy
Dendreon & a Diagnostic for Provenge?
New Online Tool & Tips on Bone Health
New Provenge Plant Opens in California
Valvoline Supports Prostate Cancer Awareness
Elastography Beats Ultrasound for Detection
Ask Doctor Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – “Sage supplement may reduce hot flashes”
ERG Unrelated to PSA Recurrence w/o ADT
Doctor Chodak’s Bottom Line
Read more..

November | Newsletter

USPSTF Says PSA Test Does Not Save Lives
FDA Approves Prolia for Treating Bone Loss in Men and Women on Hormone Ablation
Erections after Prostate Treatment Predicted by Models
Us TOO Seeks Board Member Applications
Ask Doctor Snuffy Myers
Call to Action – Comment on USPSTF’s Draft Recommendation Statement Against PSA-Based Screening for Prostate Cancer
SEA Blue Prostate Walk Shines Despite Rain
2011 Us TOO University Opens Diaglogue With Support Group Leaders
Doc Moyad’s “No Bogus Science” Column – 1) Vitamin E and Prostate Cancer Death; 2) What the USPSTF Should Have Stated
Doctor Chodak’s Bottom Line
Read more..

December | Newsletter

Share Hope and Donate to Us TOO
MDV3100 Trial Stopped as Survival Improved
Top Doctors Support PSA Screening in Men
Brachytherapy & Risk of a Second Cancer
Antibiotic Change Before Prostate Biopsy
Men with a Family History of Prostate Cancer Do Not Need More Aggressive Treatment
ADT Duration & Risk of Prostate Cancer Death
New NCI Trial for Taxotere-Resistance Cancer
Quanterix PSA Test to Predict PSA Recurrence
Ask Doctor Snuffy Myers
[11C]choline PET-CT for Detecting Pelvic Nodes
Doc Moyad’s “No Bogus Science” Column – “Metformin and Lifestyle Changes”
Doctor Chodak’s Bottom Line
RT + ADT Extends Life in Advanced Cancer
Read more..